uric acid has been researched along with Nephrolithiasis in 109 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Nephrolithiasis: Formation of stones in the KIDNEY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Both type 4 RTA and uric acid nephrolithiasis disproportionately occur in patients with type 2 diabetes and/or chronic kidney disease." | 9.41 | Type 4 renal tubular acidosis and uric acid nephrolithiasis: two faces of the same coin? ( Adomako, EA; Maalouf, NM, 2023) |
| "Uric acid nephrolithiasis (UAN) is an increasingly common disease in ethnically diverse populations and constitutes about 10% of all kidney stones." | 8.98 | Metabolic syndrome and uric acid nephrolithiasis: insulin resistance in focus. ( Badalamenti, S; Dauriz, M; Ferraro, PM; Gambaro, G; Spatola, L, 2018) |
| "Uric acid nephrolithiasis appears to increase in prevalence." | 8.98 | Uric acid nephrolithiasis: An update. ( Cicerello, E, 2018) |
| "Uric acid stones are significantly more common among nephrolithiasis patients with type 2 diabetes, obesity, and/or the metabolic syndrome." | 8.87 | Metabolic syndrome and the genesis of uric acid stones. ( Maalouf, NM, 2011) |
| "Uric acid nephrolithiasis is typically found in individuals with a low urine pH and a normal concentration of urinary uric acid." | 8.84 | Uric acid nephrolithiasis. ( Bushinsky, DA; Liebman, SE; Taylor, JG, 2007) |
| " The prevalence of uric acid nephrolithiasis is higher among stone-forming patients with features of the metabolic syndrome such as obesity and/or type 2 diabetes mellitus." | 8.84 | Metabolic syndrome and uric acid nephrolithiasis. ( Maalouf, NM; Sakhaee, K, 2008) |
| "Uric acid nephrolithiasis may be the final manifestation of various pathophysiological processes." | 8.84 | Uric acid nephrolithiasis. ( Cameron, MA; Sakhaee, K, 2007) |
| "The majority of uric acid nephrolithiasis in humans occurs in the absence of frank hyperuricosuria and is primarily a disease of excessively low urinary pH." | 8.83 | Uric acid nephrolithiasis: proton titration of an essential molecule? ( Moe, OW, 2006) |
| "The effect of carnosine on MMP-2 activity and oxidative stress in the kidneys in experimental urate nephrolithiasis was studied." | 8.31 | Effect of Carnosine on the Activity of Matrix Metalloproteinase-2 and Oxidative Stress in the Kidneys in Experimental Urate Nephrolithiasis. ( Bobrov, IP; Kalnitsky, AS; Makarova, OG; Mazko, ON; Zharikov, AY, 2023) |
| "The prospect of using the antioxidant dipeptide carnosine for the treatment of urate nephrolithiasis was evaluated." | 8.02 | Effect of Carnosine on the Course of Experimental Urate Nephrolithiasis. ( Azarova, OV; Bobrov, IP; Kalnitsky, AS; Makarova, OG; Mazko, ON; Zharikov, AY, 2021) |
| "01) effectiveness of A-MNPs in management of hyperuricemic nephrolithiasis was observed through estimating pH and uric acid levels in urine and serum samples of mice." | 7.91 | Targeting kidneys by superparamagnetic allopurinol loaded chitosan coated nanoparticles for the treatment of hyperuricemic nephrolithiasis. ( Bhatt, DC; Jindal, DK; Kandav, G, 2019) |
| "Uric acid (UA) nephrolithiasis represents 10% of kidney stones in the US with low urine pH and high saturation of UA as the main risk factors for stone development." | 7.91 | Medical dissolution therapy for the treatment of uric acid nephrolithiasis. ( Gridley, CM; Knudsen, BE; Lehman, A; Sourial, MW, 2019) |
| "Numerous epidemiological studies have shown that male patients with uric acid nephrolithiasis outnumber female patients." | 7.88 | Mediators of the Effects of Gender on Uric Acid Nephrolithiasis: A Novel Application of Structural Equation Modeling. ( Chang, YY; Chen, HW; Chen, YC; Chou, YH; Li, CC; Wu, WJ; Yang, FM, 2018) |
| "8 units), which will allow to avoid deposition of other crystals upon the existing stone and identify indicators reflecting the degree of metabolic disorders in patients with uric acid nephrolithiasis." | 7.83 | [Modern diagnostic and management aspects of citrate therapy for uric acid nephrolithiasis]. ( Alekseenko, SN; Medvedev, VL; Ryabokon', SS; Tatevosyan, AS; Tonyan, AG, 2016) |
| " About 5-10% of all kidney stones is composed of uric acid, however the prevalence of uric acid stones significantly increases among patients with obesity, diabetes or metabolic syndrome." | 7.81 | [Uric acid nephrolithiasis]. ( Ferraro, PM; Gambaro, G, 2015) |
| "To assess the capacity of methylxanthines (caffeine, theophylline, theobromine and paraxanthine) to inhibit uric acid crystallization, and to evaluate their potential application in the treatment of uric acid nephrolithiasis." | 7.80 | Theobromine inhibits uric acid crystallization. A potential application in the treatment of uric acid nephrolithiasis. ( Costa-Bauza, A; Grases, F; Rodriguez, A, 2014) |
| "Uric acid nephrolithiasis is frequent accounting for 10% of urinary stones in industrialized countries." | 7.77 | [Uric acid nephrolithiasis]. ( Dussol, B, 2011) |
| "Type 2 diabetes mellitus (T2DM) is an independent risk factor for uric acid nephrolithiasis, and obesity augments this risk." | 7.77 | Analysis of risk factors for uric acid nephrolithiasis in type 2 diabetes. ( Hari Kumar, KV; Modi, KD, 2011) |
| "Both type 4 RTA and uric acid nephrolithiasis disproportionately occur in patients with type 2 diabetes and/or chronic kidney disease." | 5.41 | Type 4 renal tubular acidosis and uric acid nephrolithiasis: two faces of the same coin? ( Adomako, EA; Maalouf, NM, 2023) |
| "The combined consumption of citrate and theobromine may be a promising strategy for the prevention of UA kidney stones." | 5.34 | Comparison of Two Dietary Supplements for Treatment of Uric Acid Renal Lithiasis: Citrate vs. Citrate + Theobromine. ( Benejam, J; Calvó, P; Costa-Bauza, A; Grases, F; Hernandez, Y; Sanchis, P, 2020) |
| " Study design: We present a case of a 10-year-old boy with metastatic clear cell renal cell carcinoma (ccRCC) of the right kidney and an acute renal failure of the left kidney secondary to uric acid nephrolithiasis." | 5.22 | Clear Cell Renal Cell Carcinoma, Diagnostic and Therapeutic Difficulties, Case Report and Literature Review. ( Mizia-Malarz, A; Stolpa, W; Stręk-Cholewińska, A, 2022) |
| "Type 2 diabetes is associated with excessively low urine pH, which increases the risk for uric acid nephrolithiasis." | 5.14 | Metabolic basis for low urine pH in type 2 diabetes. ( Cameron, MA; Maalouf, NM; Moe, OW; Sakhaee, K, 2010) |
| "Uric acid nephrolithiasis (UAN) is an increasingly common disease in ethnically diverse populations and constitutes about 10% of all kidney stones." | 4.98 | Metabolic syndrome and uric acid nephrolithiasis: insulin resistance in focus. ( Badalamenti, S; Dauriz, M; Ferraro, PM; Gambaro, G; Spatola, L, 2018) |
| "Uric acid nephrolithiasis appears to increase in prevalence." | 4.98 | Uric acid nephrolithiasis: An update. ( Cicerello, E, 2018) |
| " Apart from the diagnostic criteria, MetS has also been associated with other risk factors including waist to hip ratio, high density lipoprotein dysfunction, small dense low density lipoprotein, postprandial hypertriglyceridaemia, lipoprotein (a), uric acid, liver function tests, prothrombotic factors, cytokines, adipokines, vitamin D, arterial stiffness, renal dysfunction, nephrolithiasis, polycystic ovary syndrome, obstructive sleep apnea." | 4.90 | Characteristics other than the diagnostic criteria associated with metabolic syndrome: an overview. ( Athyros, VG; Karagiannis, A; Katsiki, N; Mikhailidis, DP, 2014) |
| "There is an increased prevalence of nephrolithiasis and an increase in the incidence of renal colic in patients with diabetes, obesity, hypertension and insulin resistance because of an increased frequency of uric acid crystallization." | 4.88 | Beware the low urine pH--the major cause of the increased prevalence of nephrolithiasis in the patient with type 2 diabetes. ( Bell, DS, 2012) |
| "Uric acid stones are significantly more common among nephrolithiasis patients with type 2 diabetes, obesity, and/or the metabolic syndrome." | 4.87 | Metabolic syndrome and the genesis of uric acid stones. ( Maalouf, NM, 2011) |
| " These advances have led to our further understanding of a pathogenetic link between uric acid nephrolithiasis and the metabolic syndrome, the role of Oxalobacter formigenes in calcium oxalate stone formation, oxalate transport in Slc26a6-null mice, the potential pathogenetic role of Randall's plaque as a precursor for calcium oxalate nephrolithiasis, and the role of renal tubular crystal retention." | 4.85 | Recent advances in the pathophysiology of nephrolithiasis. ( Sakhaee, K, 2009) |
| " Finally, alternative measures for reducing urinary risk factors, such as probiotics, show promise in reducing urinary oxalate and may be effective in the treatment of primary and enteric hyperoxaluria or even idiopathic calcium oxalate nephrolithiasis." | 4.85 | Update on the medical management of stone disease. ( Pearle, MS; Tracy, CR, 2009) |
| "Uric acid nephrolithiasis is typically found in individuals with a low urine pH and a normal concentration of urinary uric acid." | 4.84 | Uric acid nephrolithiasis. ( Bushinsky, DA; Liebman, SE; Taylor, JG, 2007) |
| " The prevalence of uric acid nephrolithiasis is higher among stone-forming patients with features of the metabolic syndrome such as obesity and/or type 2 diabetes mellitus." | 4.84 | Metabolic syndrome and uric acid nephrolithiasis. ( Maalouf, NM; Sakhaee, K, 2008) |
| "The majority of uric acid nephrolithiasis in humans occurs in the absence of frank hyperuricosuria and is primarily a disease of excessively low urinary pH." | 4.83 | Uric acid nephrolithiasis: proton titration of an essential molecule? ( Moe, OW, 2006) |
| "The effect of carnosine on MMP-2 activity and oxidative stress in the kidneys in experimental urate nephrolithiasis was studied." | 4.31 | Effect of Carnosine on the Activity of Matrix Metalloproteinase-2 and Oxidative Stress in the Kidneys in Experimental Urate Nephrolithiasis. ( Bobrov, IP; Kalnitsky, AS; Makarova, OG; Mazko, ON; Zharikov, AY, 2023) |
| "The prospect of using the antioxidant dipeptide carnosine for the treatment of urate nephrolithiasis was evaluated." | 4.02 | Effect of Carnosine on the Course of Experimental Urate Nephrolithiasis. ( Azarova, OV; Bobrov, IP; Kalnitsky, AS; Makarova, OG; Mazko, ON; Zharikov, AY, 2021) |
| "01) effectiveness of A-MNPs in management of hyperuricemic nephrolithiasis was observed through estimating pH and uric acid levels in urine and serum samples of mice." | 3.91 | Targeting kidneys by superparamagnetic allopurinol loaded chitosan coated nanoparticles for the treatment of hyperuricemic nephrolithiasis. ( Bhatt, DC; Jindal, DK; Kandav, G, 2019) |
| "Uric acid (UA) nephrolithiasis represents 10% of kidney stones in the US with low urine pH and high saturation of UA as the main risk factors for stone development." | 3.91 | Medical dissolution therapy for the treatment of uric acid nephrolithiasis. ( Gridley, CM; Knudsen, BE; Lehman, A; Sourial, MW, 2019) |
| "A study to evaluate the prevalence of uric acid (UA) nephrolithiasis with dual-energy CT (DECT) and explore the risk factors for kidney stones in primary gout patients." | 3.91 | Evaluation of the chemical composition of nephrolithiasis using dual-energy CT in Southern Chinese gout patients. ( Bashir, S; Cheng, ZY; Jiao, GL; Li, ZX; Zhou, SM; Zhou, Y, 2019) |
| "Numerous epidemiological studies have shown that male patients with uric acid nephrolithiasis outnumber female patients." | 3.88 | Mediators of the Effects of Gender on Uric Acid Nephrolithiasis: A Novel Application of Structural Equation Modeling. ( Chang, YY; Chen, HW; Chen, YC; Chou, YH; Li, CC; Wu, WJ; Yang, FM, 2018) |
| " A correlation was identified between increased amounts of uric acid and biomarkers of lipid peroxidation in patients with nephrolithiasis, both before and after ESWL." | 3.88 | The lipid peroxidation in patients with nephrolithiasis before and after extracorporeal shock wave lithotripsy. ( Kontek, B; Olas, B; Różański, W; Woźniak, P, 2018) |
| "To determine if there is correlation between nighttime 12-hour and traditional 24-hour urine collection in regard to chemistry values and the supersaturations of calcium oxalate, calcium phosphate, and uric acid for the metabolic evaluation of nephrolithiasis." | 3.85 | Can a Simplified 12-Hour Nighttime Urine Collection Predict Urinary Stone Risk? ( Asplin, J; Calle, J; Ganesan, V; Granja, I; Hinck, BD; Monga, M; Sivalingam, S; Tarplin, S, 2017) |
| " Metabolic abnormalities were significantly more present in patients with mixed infected stones (struvite+/-apatite and calcium oxalate) than in patients with pure infected stones (struvite+/-carbonate apatite): hypercalciuria in 40%, hyperoxaluria in 34% and hyperuricosuria in 28% (p < 0." | 3.83 | Metabolic evaluation in patients with infected nephrolithiasis: Is it necessary? ( Cicerello, E; Cova, GD; Maccatrozzo, L; Mangano, M; Merlo, F, 2016) |
| "8 units), which will allow to avoid deposition of other crystals upon the existing stone and identify indicators reflecting the degree of metabolic disorders in patients with uric acid nephrolithiasis." | 3.83 | [Modern diagnostic and management aspects of citrate therapy for uric acid nephrolithiasis]. ( Alekseenko, SN; Medvedev, VL; Ryabokon', SS; Tatevosyan, AS; Tonyan, AG, 2016) |
| " About 5-10% of all kidney stones is composed of uric acid, however the prevalence of uric acid stones significantly increases among patients with obesity, diabetes or metabolic syndrome." | 3.81 | [Uric acid nephrolithiasis]. ( Ferraro, PM; Gambaro, G, 2015) |
| " Urinary risk factors for nephrolithiasis and urine saturation with respect to calcium oxalate and uric acid (assessed as supersaturation index [SI]) were correlated with various measures of adiposity." | 3.80 | Body fat content and distribution and urinary risk factors for nephrolithiasis. ( Adams-Huet, B; Maalouf, NM; Pigna, F; Sakhaee, K, 2014) |
| "To assess the capacity of methylxanthines (caffeine, theophylline, theobromine and paraxanthine) to inhibit uric acid crystallization, and to evaluate their potential application in the treatment of uric acid nephrolithiasis." | 3.80 | Theobromine inhibits uric acid crystallization. A potential application in the treatment of uric acid nephrolithiasis. ( Costa-Bauza, A; Grases, F; Rodriguez, A, 2014) |
| "Metabolic syndrome trait clustering is associated with greater severity of kidney stone disease; increased urinary calcium, uric acid, and oxalate excretion; and decreased urinary citrate excretion." | 3.79 | Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan. ( Hara, I; Iguchi, M; Inagaki, T; Kohjimoto, Y; Matsumura, N; Sasaki, Y, 2013) |
| " A clinical study on 467 patients with nephrolithiasis at our institution revealed that clustering of MetS traits increased the risk of uric acid stone formation by decreasing urinary pH." | 3.77 | [Metabolic syndrome and nephrolithiasis]. ( Hara, I; Iba, A; Kohjimoto, Y; Sasaki, Y, 2011) |
| "In contrast to large GWA studies based on thousands of individuals and large meta-analyses combining GWAS results, we analyzed a small case/control sample for uric acid nephrolithiasis." | 3.77 | Application of a new method for GWAS in a related case/control sample with known pedigree structure: identification of new loci for nephrolithiasis. ( Bonerba, B; Caruso, MR; Casu, G; Casula, S; Concas, MP; Deiana, I; Forabosco, P; Maestrale, GB; Mele, C; Persico, I; Pirastu, M; Pistidda, P; Sassu, A; Thornton, T; Tore, S; Usai, P, 2011) |
| " We included non-stone forming subjects and stone formers with hypercalciuria, distal renal tubular acidosis, idiopathic uric acid nephrolithiasis, or chronic diarrhea." | 3.77 | Fasting versus 24-h urine pH in the evaluation of nephrolithiasis. ( Capolongo, G; Maalouf, NM; Pak, CY; Sakhaee, K, 2011) |
| "Type 2 diabetes mellitus (T2DM) is an independent risk factor for uric acid nephrolithiasis, and obesity augments this risk." | 3.77 | Analysis of risk factors for uric acid nephrolithiasis in type 2 diabetes. ( Hari Kumar, KV; Modi, KD, 2011) |
| "Patients with blood hypertension and nephrolithiasis present higher calciuria than healthy people, with hypertension or with lithiasis and do not have the positive correlation observed in these latter groups with renal excretion of uric acid and sodium." | 3.75 | Patients with nephrolithiasis and blood hypertension have higher calciuria than those with isolated nephrolithiasis or hypertension? ( Casulari, LA; Costa, SS; Reis, MC; Rodrigues, MP; Schleicher, MM, 2009) |
| " Hyperuricemia leads to hyperuricuria and uric acid nephrolithiasis." | 3.74 | Rare variant of Lesch-Nyhan syndrome without self-mutilation or nephrolithiasis. ( Kersnik Levart, T, 2007) |
| "Type 2 diabetes is associated with an increased risk of nephrolithiasis, specifically in the form of uric acid (UA) nephrolithiasis." | 3.74 | Diabetes and nephrolithiasis. ( Daudon, M; Jungers, P, 2007) |
| "Recently, nephrolithiasis has been reported to be involved with renal manifestation of metabolic syndrome." | 2.73 | Relationship between insulin resistance and low urinary pH in patients with gout, and effects of PPARalpha agonists on urine pH. ( Inokuchi, T; Ka, T; Kobayashi, T; Moriwaki, Y; Takahashi, S; Tsutsumi, Z; Yamamoto, T, 2007) |
| "The calcic nephrolithiasis is the more frequent subtype (>80%)." | 2.55 | [Nephrolithiasis of adult: From mechanisms to preventive medical treatment]. ( Baron, S; Bertocchio, JP; Briand, S; Courbebaisse, M; Daudon, M; Houillier, P; Maruani, G; Prot-Bertoye, C, 2017) |
| "Uric acid appears to cause salting out of calcium oxalate in human urine." | 2.50 | Treatment of calcium nephrolithiasis in the patient with hyperuricosuria. ( Arowojolu, O; Goldfarb, DS, 2014) |
| "Kidney stones are a common disorder of the urinary tract." | 2.44 | Stone composition: where do we stand? ( Bonaccorsi, A; Motta, M; Saita, A, 2007) |
| "However, hyperuricemia was often used as an accompanying symptom of gout to explore its association with nephrolithiasis, there were few studies to explore whether hyperuricemia itself or serum uric acid (SUA) is related to the risk of nephrolithiasis." | 1.91 | Asymptomatic hyperuricemia associated with increased risk of nephrolithiasis: a cross-sectional study. ( Cheng, N; Deng, H; Hou, Z; Li, Y; Meng, Q; Song, C; Sun, Y; Wang, Q; Yin, J; Zhang, J; Zhang, X, 2023) |
| "Uric acid lithiasis accounts for about 10% of all types of renal lithiasis." | 1.91 | Efficacy of Theobromine and Its Metabolites in Reducing the Risk of Uric Acid Lithiasis. ( Calvó, P; Costa-Bauzá, A; Grases, F; Hernández, Y, 2023) |
| "Nephrolithiasis is a common complication of primary hyperparathyroidism (PHPT), and the recurrence of nephrolithiasis in patients with PHPT is also an urgent concern." | 1.72 | Development and validation of a nomogram for risk prediction of nephrolithiasis recurrence in patients with primary hyperparathyroidism. ( Chu, X; Dai, Y; Jiang, D; Qi, H; Tang, Y; Wu, X; Xu, J; Zhou, Y, 2022) |
| "Thirty infants with nephrolithiasis and 30 healthy infants exclusively breastfed for the first 6 months of life were included in this prospective cohort case-control study." | 1.62 | Nephrolithiasis during the first 6 months of life in exclusively breastfed infants. ( Altıntaş, F; Koçyiğit, A; Yılmaz, N; Yüksel, S, 2021) |
| "Nephrolithiasis is one of the most common urinary tract diseases." | 1.48 | Study of Urine Composition of Patients With Recurrent Nephrolithiasis in Lorestan, Iran. ( Ghorbani, F; Hadian, B; Zafar-Mohtashami, A, 2018) |
| "Patients with UA nephrolithiasis have normal acid-base parameters assessed according to conventional clinical tests." | 1.48 | Uric Acid Renal Lithiasis: New Concepts. ( Pazos Pérez, F, 2018) |
| "Nephrolithiasis is increasingly reported in bottle-nosed dolphins." | 1.40 | Pathophysiological and physicochemical basis of ammonium urate stone formation in dolphins. ( Bobulescu, IA; Jensen, ED; Meegan, JM; Poindexter, JR; Sakhaee, K; Smith, CR; Venn-Watson, S, 2014) |
| "No patient without evidence of nephrolithiasis developed a stone event, whereas 13/39 (33%) of those with nephrolithiasis developed a recurrent stone event." | 1.38 | Nephrolithiasis in medullary sponge kidney: evaluation of clinical and metabolic features. ( Gettman, MT; Krambeck, AE; McPhail, EF; Patterson, DE; Rangel, LJ, 2012) |
| "Nephroliths were found throughout both kidneys during necropsy examination, varying in size from 1-10 mm in diameter in the northern elephant seal and from 1-15 mm in diameter in the California sea lion." | 1.34 | Urate nephrolithiasis in a northern elephant seal (Mirounga angustirostris) and a California sea lion (Zalophus californianus). ( Colegrove, K; De Morais, H; Dennison, S; Gulland, F; Haulena, M, 2007) |
| "In calcium and phosphate urolithiasis, dietary therapy is a very useful adjunct." | 1.23 | Some aspects of the management of bilateral calculus disease of the kidney. ( FLOCKS, RH, 1950) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (6.42) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 21 (19.27) | 29.6817 |
| 2010's | 60 (55.05) | 24.3611 |
| 2020's | 21 (19.27) | 2.80 |
| Authors | Studies |
|---|---|
| Wen, W | 1 |
| Li, Y | 2 |
| Chen, Q | 1 |
| Li, J | 1 |
| Qin, L | 1 |
| Zhou, J | 1 |
| Hu, W | 1 |
| Zhang, H | 1 |
| Tang, Y | 2 |
| Li, M | 1 |
| Zhou, Y | 2 |
| Chu, X | 1 |
| Jiang, D | 1 |
| Wu, X | 1 |
| Xu, J | 1 |
| Qi, H | 1 |
| Dai, Y | 1 |
| Stolpa, W | 1 |
| Stręk-Cholewińska, A | 1 |
| Mizia-Malarz, A | 1 |
| Frolova, EA | 1 |
| Tsarichenko, DG | 1 |
| Saenko, VS | 1 |
| Rapoport, LM | 1 |
| Glybochko, PV | 1 |
| Klib, M | 1 |
| Ghandour, M | 1 |
| Wannous, H | 1 |
| Adomako, EA | 1 |
| Maalouf, NM | 6 |
| Zharikov, AY | 2 |
| Kalnitsky, AS | 2 |
| Mazko, ON | 2 |
| Makarova, OG | 2 |
| Bobrov, IP | 2 |
| Wang, Z | 1 |
| Yang, G | 1 |
| Wang, X | 1 |
| Cao, Y | 1 |
| Jiao, W | 1 |
| Niu, H | 1 |
| Lin, CT | 1 |
| Chen, IC | 1 |
| Chen, YJ | 1 |
| Lin, YC | 1 |
| Chang, JC | 1 |
| Wang, TJ | 1 |
| Huang, WN | 1 |
| Chen, YH | 2 |
| Lin, CH | 1 |
| Chen, YM | 1 |
| Ong, A | 1 |
| Brown, G | 1 |
| Tokas, T | 1 |
| Hameed, BMZ | 1 |
| Philip, J | 1 |
| Somani, BK | 1 |
| Pranovich, AA | 1 |
| Kalinin, DV | 1 |
| Sultanova, NO | 1 |
| Stepanova, YA | 1 |
| Borukaev, AY | 1 |
| Costa-Bauzá, A | 4 |
| Calvó, P | 2 |
| Hernández, Y | 2 |
| Grases, F | 4 |
| Shen, X | 1 |
| Pan, Q | 1 |
| Huang, Y | 1 |
| You, J | 1 |
| Chen, Y | 2 |
| Ding, X | 1 |
| Deng, H | 1 |
| Zhang, X | 1 |
| Cheng, N | 1 |
| Zhang, J | 1 |
| Song, C | 1 |
| Sun, Y | 1 |
| Hou, Z | 1 |
| Wang, Q | 1 |
| Yin, J | 1 |
| Meng, Q | 1 |
| Kandav, G | 1 |
| Bhatt, DC | 1 |
| Jindal, DK | 1 |
| Tonyali, S | 1 |
| Benejam, J | 1 |
| Sanchis, P | 1 |
| Yılmaz, N | 1 |
| Yüksel, S | 1 |
| Altıntaş, F | 1 |
| Koçyiğit, A | 1 |
| Bu, Q | 1 |
| Zhu, Y | 1 |
| Chen, QY | 1 |
| Li, H | 1 |
| Pan, Y | 1 |
| Abu-Ghanem, Y | 2 |
| Kleinmann, N | 2 |
| Erlich, T | 1 |
| Winkler, HZ | 2 |
| Zilberman, DE | 2 |
| Azarova, OV | 1 |
| Ardente, AJ | 1 |
| Wells, RS | 2 |
| Smith, CR | 3 |
| Walsh, MT | 1 |
| Jensen, ED | 2 |
| Schmitt, TL | 1 |
| Colee, J | 1 |
| Vagt, BJ | 1 |
| Hill, RC | 1 |
| Li, X | 1 |
| Meng, X | 1 |
| Timofeeva, M | 1 |
| Tzoulaki, I | 1 |
| Tsilidis, KK | 1 |
| Ioannidis, JP | 1 |
| Campbell, H | 1 |
| Theodoratou, E | 1 |
| Hinck, BD | 1 |
| Ganesan, V | 1 |
| Tarplin, S | 1 |
| Asplin, J | 1 |
| Granja, I | 1 |
| Calle, J | 2 |
| Sivalingam, S | 1 |
| Monga, M | 2 |
| Otto, BJ | 1 |
| Bozorgmehri, S | 1 |
| Kuo, J | 1 |
| Canales, M | 1 |
| Bird, VG | 1 |
| Canales, B | 1 |
| Pazos Pérez, F | 1 |
| Hadian, B | 1 |
| Zafar-Mohtashami, A | 1 |
| Ghorbani, F | 1 |
| Spatola, L | 1 |
| Ferraro, PM | 2 |
| Gambaro, G | 2 |
| Badalamenti, S | 1 |
| Dauriz, M | 1 |
| Chen, HW | 1 |
| Chen, YC | 1 |
| Yang, FM | 1 |
| Wu, WJ | 1 |
| Li, CC | 1 |
| Chang, YY | 1 |
| Chou, YH | 1 |
| Cicerello, E | 3 |
| Shvero, A | 1 |
| Maciolek, KA | 1 |
| Penniston, KL | 1 |
| Jhagroo, RA | 1 |
| Best, SL | 1 |
| Woźniak, P | 1 |
| Kontek, B | 1 |
| Różański, W | 1 |
| Olas, B | 1 |
| Gridley, CM | 1 |
| Sourial, MW | 1 |
| Lehman, A | 1 |
| Knudsen, BE | 1 |
| Assimos, DG | 2 |
| Li, ZX | 1 |
| Jiao, GL | 1 |
| Zhou, SM | 1 |
| Cheng, ZY | 1 |
| Bashir, S | 1 |
| Niu, SW | 1 |
| He, JS | 1 |
| You-Hsien Lin, H | 1 |
| Kohjimoto, Y | 2 |
| Sasaki, Y | 2 |
| Iguchi, M | 1 |
| Matsumura, N | 1 |
| Inagaki, T | 1 |
| Hara, I | 2 |
| Rendina, D | 1 |
| De Filippo, G | 1 |
| De Pascale, F | 1 |
| Zampa, G | 1 |
| Muscariello, R | 1 |
| De Palma, D | 1 |
| Ippolito, R | 1 |
| Strazzullo, P | 1 |
| Katsiki, N | 1 |
| Athyros, VG | 1 |
| Karagiannis, A | 1 |
| Mikhailidis, DP | 1 |
| Pigna, F | 1 |
| Sakhaee, K | 7 |
| Adams-Huet, B | 1 |
| Doucet, BP | 1 |
| Jegatheesan, D | 1 |
| Burke, J | 1 |
| Torricelli, FC | 1 |
| De, S | 1 |
| Liu, X | 1 |
| Gebreselassie, S | 1 |
| Poindexter, JR | 1 |
| Meegan, JM | 1 |
| Bobulescu, IA | 1 |
| Venn-Watson, S | 1 |
| Friedlander, JI | 2 |
| Moreira, DM | 2 |
| Hartman, C | 2 |
| Elsamra, SE | 2 |
| Smith, AD | 2 |
| Okeke, Z | 2 |
| Arowojolu, O | 1 |
| Goldfarb, DS | 1 |
| Fu, W | 1 |
| Li, Q | 1 |
| Yao, J | 1 |
| Zheng, J | 1 |
| Lang, L | 1 |
| Li, W | 1 |
| Yan, J | 1 |
| Rodriguez, A | 1 |
| Xue, Y | 1 |
| Zhang, P | 1 |
| Yang, X | 1 |
| Chong, T | 1 |
| Orhan, N | 1 |
| Onaran, M | 1 |
| Şen, İ | 1 |
| Işık Gönül, İ | 1 |
| Aslan, M | 1 |
| Kummer, AE | 1 |
| Grams, M | 1 |
| Lutsey, P | 1 |
| Matsushita, K | 1 |
| Köttgen, A | 1 |
| Folsom, AR | 1 |
| Coresh, J | 1 |
| Kim, MJ | 1 |
| Hopfer, H | 1 |
| Mayr, M | 1 |
| Courbebaisse, M | 1 |
| Prot-Bertoye, C | 1 |
| Bertocchio, JP | 1 |
| Baron, S | 1 |
| Maruani, G | 1 |
| Briand, S | 1 |
| Daudon, M | 2 |
| Houillier, P | 1 |
| Girón-Prieto, MS | 1 |
| Arias-Santiago, S | 1 |
| Del Carmen Cano-García, M | 1 |
| Poyatos-Andújar, A | 1 |
| de Haro-Muñoz, T | 1 |
| Abad-Menor, F | 1 |
| Quesada-Charneco, M | 1 |
| Arrabal-Polo, MÁ | 1 |
| Arrabal-Martín, M | 1 |
| Pfau, A | 1 |
| Knauf, F | 1 |
| Mangano, M | 1 |
| Cova, GD | 1 |
| Merlo, F | 2 |
| Maccatrozzo, L | 2 |
| Al'-Shukri, SK | 1 |
| Slesarevskaya, MN | 1 |
| Kuz'min, IV | 1 |
| Alekseenko, SN | 1 |
| Tatevosyan, AS | 1 |
| Medvedev, VL | 1 |
| Tonyan, AG | 1 |
| Ryabokon', SS | 1 |
| Nepal, M | 1 |
| Bock, GH | 1 |
| Sehic, AM | 1 |
| Schultz, MF | 1 |
| Zhang, PL | 1 |
| Tracy, CR | 1 |
| Pearle, MS | 1 |
| Schleicher, MM | 1 |
| Reis, MC | 1 |
| Costa, SS | 1 |
| Rodrigues, MP | 1 |
| Casulari, LA | 1 |
| Hall, PM | 1 |
| Dinour, D | 1 |
| Gray, NK | 1 |
| Campbell, S | 1 |
| Shu, X | 1 |
| Sawyer, L | 1 |
| Richardson, W | 1 |
| Rechavi, G | 1 |
| Amariglio, N | 1 |
| Ganon, L | 1 |
| Sela, BA | 1 |
| Bahat, H | 1 |
| Goldman, M | 1 |
| Weissgarten, J | 1 |
| Millar, MR | 1 |
| Wright, AF | 1 |
| Holtzman, EJ | 1 |
| Eisner, BH | 2 |
| Eisenberg, ML | 1 |
| Stoller, ML | 1 |
| Venn-Watson, SK | 1 |
| Townsend, FI | 1 |
| Daniels, RL | 1 |
| Sweeney, JC | 1 |
| McBain, JW | 1 |
| Klatsky, LJ | 1 |
| Hicks, CL | 1 |
| Staggs, LA | 1 |
| Rowles, TK | 1 |
| Schwacke, LH | 1 |
| Cameron, MA | 2 |
| Moe, OW | 2 |
| Boonla, C | 1 |
| Youngjermchan, P | 1 |
| Pumpaisanchai, S | 1 |
| Tungsanga, K | 1 |
| Tosukhowong, P | 1 |
| Tore, S | 1 |
| Casula, S | 1 |
| Casu, G | 1 |
| Concas, MP | 1 |
| Pistidda, P | 1 |
| Persico, I | 1 |
| Sassu, A | 1 |
| Maestrale, GB | 1 |
| Mele, C | 1 |
| Caruso, MR | 1 |
| Bonerba, B | 1 |
| Usai, P | 1 |
| Deiana, I | 1 |
| Thornton, T | 1 |
| Pirastu, M | 1 |
| Forabosco, P | 1 |
| Iba, A | 1 |
| Capolongo, G | 1 |
| Pak, CY | 1 |
| Dussol, B | 1 |
| Hari Kumar, KV | 1 |
| Modi, KD | 1 |
| Gomila, I | 1 |
| Ramis, M | 1 |
| García-Raja, A | 1 |
| Prieto, RM | 1 |
| Kadlec, AO | 1 |
| Greco, KA | 1 |
| Fridirici, ZC | 1 |
| Gerber, D | 1 |
| Turk, TM | 1 |
| Bell, DS | 1 |
| McPhail, EF | 1 |
| Gettman, MT | 1 |
| Patterson, DE | 1 |
| Rangel, LJ | 1 |
| Krambeck, AE | 1 |
| Guo, WP | 1 |
| Fung, YS | 1 |
| McMahon, GM | 1 |
| Seifter, JL | 1 |
| Sheth, S | 1 |
| Dretler, SP | 1 |
| Herrick, B | 1 |
| Pais, VM | 1 |
| ZACHARIA, S | 1 |
| PAULLADA, JJ | 1 |
| SERANE, J | 1 |
| PEAN, C | 1 |
| THOMAS, J | 1 |
| THOMAS, E | 1 |
| RABUSSIER, H | 1 |
| DESGREZ, P | 1 |
| RINGOIR, S | 1 |
| VERMOOTEN, V | 1 |
| FLOCKS, RH | 1 |
| Terribile, M | 1 |
| Capuano, M | 1 |
| Cangiano, G | 1 |
| Carnovale, V | 1 |
| Ferrara, P | 1 |
| Petrarulo, M | 1 |
| Marangella, M | 1 |
| Solov'eva, OA | 1 |
| Balkarov, IM | 1 |
| Miroshnichenko, NG | 1 |
| Kireeva, VI | 1 |
| Mohkam, M | 1 |
| Karimi, A | 1 |
| Gharib, A | 1 |
| Daneshmand, H | 1 |
| Khatami, A | 1 |
| Ghojevand, N | 1 |
| Sharifian, M | 1 |
| Dennison, S | 1 |
| Gulland, F | 1 |
| Haulena, M | 1 |
| De Morais, H | 1 |
| Colegrove, K | 1 |
| Liebman, SE | 1 |
| Taylor, JG | 1 |
| Bushinsky, DA | 1 |
| Takahashi, S | 1 |
| Inokuchi, T | 1 |
| Kobayashi, T | 1 |
| Ka, T | 1 |
| Tsutsumi, Z | 1 |
| Moriwaki, Y | 1 |
| Yamamoto, T | 1 |
| Kersnik Levart, T | 1 |
| Saita, A | 1 |
| Bonaccorsi, A | 1 |
| Motta, M | 1 |
| Negri, AL | 1 |
| Spivacow, R | 1 |
| Del Valle, E | 1 |
| Pinduli, I | 1 |
| Marino, A | 1 |
| Fradinger, E | 1 |
| Zanchetta, JR | 1 |
| Peterson, JM | 1 |
| Butani, L | 1 |
| Boari, B | 1 |
| Salmi, R | 1 |
| Rizzioli, E | 1 |
| Manfredini, R | 1 |
| Jungers, P | 1 |
| Worcester, EM | 1 |
| Coe, FL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Serum Uric Acid Levels and Initial Presentation of Cardiovascular Diseases: a CALIBER Study[NCT03425305] | 180,000 participants (Actual) | Observational | 1998-01-31 | Active, not recruiting | |||
| Apple Cider Vinegar for the Prevention of Urinary Lithiasis (APUL)[NCT04073719] | 50 participants (Anticipated) | Interventional | 2019-09-01 | Not yet recruiting | |||
| Use of Sodium Bicarbonate to Alkalinize Serum/Urine in Pediatric Patients Treated With Topiramate (Pilot Study)[NCT03354507] | 40 participants (Anticipated) | Interventional | 2018-01-31 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
23 reviews available for uric acid and Nephrolithiasis
| Article | Year |
|---|---|
Clear Cell Renal Cell Carcinoma, Diagnostic and Therapeutic Difficulties, Case Report and Literature Review.
Topics: Acute Kidney Injury; Adult; Carcinoma, Renal Cell; Child; Humans; Kidney Neoplasms; Male; Nephrolith | 2022 |
Type 4 renal tubular acidosis and uric acid nephrolithiasis: two faces of the same coin?
Topics: Acidosis, Renal Tubular; Diabetes Mellitus, Type 2; Humans; Hydrogen-Ion Concentration; Hyperkalemia | 2023 |
Selection and Outcomes for Dissolution Therapy in Uric Acid Stones: A Systematic Review of Literature.
Topics: Conservative Treatment; Humans; Kidney Calculi; Nephrolithiasis; Solubility; Uric Acid; Urinary Calc | 2023 |
Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies.
Topics: Biomarkers; Gout; Humans; Mendelian Randomization Analysis; Nephrolithiasis; Observational Studies a | 2017 |
Metabolic syndrome and uric acid nephrolithiasis: insulin resistance in focus.
Topics: Humans; Insulin Resistance; Metabolic Syndrome; Nephrolithiasis; Prevalence; Risk Factors; Uric Acid | 2018 |
Uric acid nephrolithiasis: An update.
Topics: Humans; Kidney Calculi; Nephrolithiasis; Uric Acid | 2018 |
Characteristics other than the diagnostic criteria associated with metabolic syndrome: an overview.
Topics: Endothelium, Vascular; Female; Humans; Hypertriglyceridemia; Lipoproteins, HDL; Lipoproteins, LDL; L | 2014 |
Treatment of calcium nephrolithiasis in the patient with hyperuricosuria.
Topics: Allopurinol; Biomarkers; Calcium Oxalate; Febuxostat; Humans; Indapamide; Kidney; Nephrolithiasis; R | 2014 |
[Uric acid, kidney disease and nephrolithiasis].
Topics: Acid-Base Equilibrium; Gout; Humans; Hyperuricemia; Insulin Resistance; Kidney; Nephrolithiasis; Ren | 2016 |
[Nephrolithiasis of adult: From mechanisms to preventive medical treatment].
Topics: Adult; Calcium, Dietary; France; Humans; Kidney Calculi; Kidney Failure, Chronic; Nephrolithiasis; R | 2017 |
Recent advances in the pathophysiology of nephrolithiasis.
Topics: Animals; Calcium Oxalate; Humans; Kidney Calculi; Kidney Tubules; Metabolic Syndrome; Nephrolithiasi | 2009 |
Update on the medical management of stone disease.
Topics: Animals; Calcium Oxalate; Citric Acid; Diet; Fructose; Humans; Nephrolithiasis; Probiotics; Secondar | 2009 |
Nephrolithiasis: treatment, causes, and prevention.
Topics: Adult; Aged; Calcium; Female; Humans; Hypercalciuria; Hyperparathyroidism; Kidney Calculi; Male; Mid | 2009 |
Urinary alkalization for the treatment of uric acid nephrolithiasis.
Topics: Humans; Hydrogen-Ion Concentration; Kidney Calculi; Nephrolithiasis; Uric Acid | 2010 |
Metabolic syndrome and the genesis of uric acid stones.
Topics: Humans; Kidney; Metabolic Syndrome; Nephrolithiasis; Uric Acid | 2011 |
Beware the low urine pH--the major cause of the increased prevalence of nephrolithiasis in the patient with type 2 diabetes.
Topics: Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Humans; Hydrogen-Ion Concentration; Insu | 2012 |
Challenges in the diagnostic and therapeutic approach to nephrolithiasis.
Topics: Citric Acid; Diet; Humans; Hydrogen-Ion Concentration; Hypercalciuria; Hyperoxaluria; Nephrolithiasi | 2012 |
Uric acid nephrolithiasis: proton titration of an essential molecule?
Topics: Animals; Antioxidants; Biological Evolution; Humans; Hydrogen-Ion Concentration; Nephrolithiasis; Ph | 2006 |
Uric acid nephrolithiasis.
Topics: Diabetes Complications; Gout; Humans; Nephrolithiasis; Uric Acid; Urine | 2007 |
Uric acid nephrolithiasis.
Topics: Humans; Nephrolithiasis; Uric Acid | 2007 |
Stone composition: where do we stand?
Topics: Calcium Oxalate; Calcium Phosphates; Crystallography; Humans; Kidney Calculi; Magnesium Compounds; N | 2007 |
Metabolic syndrome and uric acid nephrolithiasis.
Topics: Humans; Hydrogen-Ion Concentration; Metabolic Syndrome; Nephrolithiasis; Uric Acid | 2008 |
Nephrolithiasis.
Topics: Acute Disease; Humans; Hypercalciuria; Hyperoxaluria; Hyperparathyroidism; Nephrolithiasis; Risk Fac | 2008 |
5 trials available for uric acid and Nephrolithiasis
| Article | Year |
|---|---|
[Features of encrustation of ureteral stents in patients with calcium oxalate and urinary acid stones].
Topics: Calcium Oxalate; Humans; Nephrolithiasis; Stents; Ureter; Ureteral Calculi; Ureteroscopy; Uric Acid; | 2023 |
Comparison of Two Dietary Supplements for Treatment of Uric Acid Renal Lithiasis: Citrate vs. Citrate + Theobromine.
Topics: Aged; Citric Acid; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Drug Combinations; | 2020 |
The changing profile of patients with calcium nephrolithiasis and the ascendancy of overweight and obesity: a comparison of two patient series observed 25 years apart.
Topics: Adult; Biomarkers; Body Mass Index; Calcium; Female; Humans; Male; Nephrolithiasis; Obesity; Overwei | 2013 |
Metabolic basis for low urine pH in type 2 diabetes.
Topics: Adult; Age Factors; Aged; Biomarkers; Body Mass Index; Buffers; Diabetes Mellitus, Type 2; Diabetic | 2010 |
Relationship between insulin resistance and low urinary pH in patients with gout, and effects of PPARalpha agonists on urine pH.
Topics: Bezafibrate; Biomarkers; Body Mass Index; Fenofibrate; Gout; Humans; Hydrogen-Ion Concentration; Hyp | 2007 |
81 other studies available for uric acid and Nephrolithiasis
| Article | Year |
|---|---|
Serum and urine uric acid level may have different predictive value for urinary stone composition: a retrospective cohort study of 718 patients in Chinese population.
Topics: Calcium Oxalate; China; Humans; Magnesium; Male; Nephrolithiasis; Retrospective Studies; Uric Acid; | 2022 |
The combination of mean and maximum Hounsfield Unit allows more accurate prediction of uric acid stones.
Topics: Humans; Nephrolithiasis; Predictive Value of Tests; Retrospective Studies; Tomography, X-Ray Compute | 2022 |
Development and validation of a nomogram for risk prediction of nephrolithiasis recurrence in patients with primary hyperparathyroidism.
Topics: Creatinine; Humans; Hyperparathyroidism, Primary; Nephrolithiasis; Nomograms; Retrospective Studies; | 2022 |
[Dissolution of uric acid stones in the ureter].
Topics: Aged, 80 and over; Female; Humans; Kidney Calculi; Male; Nephrolithiasis; Solubility; Ureter; Ureter | 2022 |
Urinary stone disease in Syrian children.
Topics: Acute Kidney Injury; Child; Child, Preschool; Cohort Studies; Female; Humans; Infant; Kidney Calculi | 2023 |
Effect of Carnosine on the Activity of Matrix Metalloproteinase-2 and Oxidative Stress in the Kidneys in Experimental Urate Nephrolithiasis.
Topics: Animals; Carnosine; Kidney; Matrix Metalloproteinase 2; Nephrolithiasis; Oxidative Stress; Rats; Rat | 2023 |
A combined model based on CT radiomics and clinical variables to predict uric acid calculi which have a good accuracy.
Topics: Calculi; Humans; Nephrolithiasis; Retrospective Studies; Tomography, X-Ray Computed; Uric Acid | 2023 |
The
Topics: Adult; Aged; ATP Binding Cassette Transporter, Subfamily G, Member 2; Biological Specimen Banks; Cas | 2023 |
Efficacy of Theobromine and Its Metabolites in Reducing the Risk of Uric Acid Lithiasis.
Topics: Humans; Lithiasis; Nephrolithiasis; Pharmaceutical Preparations; Theobromine; Uric Acid | 2023 |
Metabolic Syndrome Predicts Uric Acid Stones in the Upper Urinary Tract: Development and Validation of a Nomogram Model.
Topics: Calcium; Humans; Metabolic Syndrome; Nephrolithiasis; Nomograms; Potassium; Retrospective Studies; U | 2023 |
Asymptomatic hyperuricemia associated with increased risk of nephrolithiasis: a cross-sectional study.
Topics: China; Cross-Sectional Studies; Female; Gout; Humans; Hyperuricemia; Male; Nephrolithiasis; Risk Fac | 2023 |
Targeting kidneys by superparamagnetic allopurinol loaded chitosan coated nanoparticles for the treatment of hyperuricemic nephrolithiasis.
Topics: Administration, Oral; Allopurinol; Animals; Chemical Precipitation; Chitosan; Disease Models, Animal | 2019 |
The efficacy of medical dissolution therapy for uric acid nephrolithiasis.
Topics: Humans; Kidney Calculi; Nephrolithiasis; Solubility; Uric Acid | 2020 |
Nephrolithiasis during the first 6 months of life in exclusively breastfed infants.
Topics: Breast Feeding; Calcium; Case-Control Studies; Citric Acid; Creatinine; Female; Humans; Infant; Kidn | 2021 |
A polymorphism in the 3'-untranslated region of the matrix metallopeptidase 9 gene is associated with susceptibility to idiopathic calcium nephrolithiasis in the Chinese population.
Topics: 3' Untranslated Regions; Adult; Asian People; Calcium; Case-Control Studies; China; Female; Gene Fre | 2020 |
The Impact of Dietary Modifications and Medical Management on 24-Hour Urinary Metabolic Profiles and the Status of Renal Stone Disease in Recurrent Stone Formers.
Topics: Aftercare; Calcium; Citric Acid; Diet Therapy; Female; Humans; Israel; Kidney Calculi; Male; Medicat | 2021 |
Effect of Carnosine on the Course of Experimental Urate Nephrolithiasis.
Topics: Animals; Antioxidants; Carnosine; Disease Models, Animal; Disease Progression; Free Radicals; Kidney | 2021 |
Dietary cation-anion difference may explain why ammonium urate nephrolithiasis occurs more frequently in common bottlenose dolphins () under human care than in free-ranging common bottlenose dolphins.
Topics: Ammonium Compounds; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Animals, Wild; | 2017 |
Can a Simplified 12-Hour Nighttime Urine Collection Predict Urinary Stone Risk?
Topics: Calcium Oxalate; Calcium Phosphates; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged | 2017 |
Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
Topics: Adolescent; Adult; Age Factors; Aged; Body Mass Index; Calcium; Calcium Oxalate; Calcium Phosphates; | 2017 |
Uric Acid Renal Lithiasis: New Concepts.
Topics: Ammonia; Humans; Hydrogen-Ion Concentration; Hyperuricemia; Insulin Resistance; Nephrolithiasis; Ris | 2018 |
Study of Urine Composition of Patients With Recurrent Nephrolithiasis in Lorestan, Iran.
Topics: Adult; Biomarkers; Calcium; Citrates; Cross-Sectional Studies; Female; Humans; Hypercalciuria; Hyper | 2018 |
Mediators of the Effects of Gender on Uric Acid Nephrolithiasis: A Novel Application of Structural Equation Modeling.
Topics: Adult; Aged; Female; Glomerular Filtration Rate; Gout; Humans; Likelihood Functions; Male; Middle Ag | 2018 |
24-h urine metabolic profile: is it necessary in all kidney stone formers?
Topics: Adult; Aged; Body Mass Index; Calcium; Citric Acid; Comorbidity; Diabetes Mellitus; Female; Humans; | 2018 |
Successful Diabetic Control as Measured by Hemoglobin A1c Is Associated with Lower Urine Risk Factors for Uric Acid Calculi.
Topics: Adult; Aged; Body Mass Index; Calcium Oxalate; Calcium Phosphates; Citrates; Diabetes Complications; | 2018 |
The lipid peroxidation in patients with nephrolithiasis before and after extracorporeal shock wave lithotripsy.
Topics: Adult; Biomarkers; Extracorporeal Shockwave Therapy; Female; Humans; Lipid Peroxidation; Lithotripsy | 2018 |
Medical dissolution therapy for the treatment of uric acid nephrolithiasis.
Topics: Adult; Aged; Allopurinol; Female; Humans; Kidney Calculi; Male; Middle Aged; Nephrolithiasis; Potass | 2019 |
Re: Net Acid Excretion and Urinary Organic Anions in Idiopathic Uric Acid Nephrolithiasis.
Topics: Anions; Humans; Kidney Calculi; Nephrolithiasis; Uric Acid | 2019 |
Evaluation of the chemical composition of nephrolithiasis using dual-energy CT in Southern Chinese gout patients.
Topics: Adult; Aged; China; Female; Gout; Humans; Kidney Calculi; Male; Middle Aged; Nephrolithiasis; Preval | 2019 |
Pioglitazone and nephrolithiasis.
Topics: Humans; Kidney Calculi; Nephrolithiasis; Pioglitazone; Uric Acid | 2019 |
Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan.
Topics: Adult; Aged; Body Mass Index; Citrates; Citric Acid; Cross-Sectional Studies; Female; Humans; Hyperc | 2013 |
Body fat content and distribution and urinary risk factors for nephrolithiasis.
Topics: Absorptiometry, Photon; Adiposity; Adult; Aged; Biomarkers; Calcium Oxalate; Cross-Sectional Studies | 2014 |
Late diagnosis of Lesch-Nyhan disease variant.
Topics: Adult; Allopurinol; Diuretics; Genetic Counseling; Gout; Gout Suppressants; Humans; Hyperuricemia; H | 2013 |
Can 24-hour urine stone risk profiles predict urinary stone composition?
Topics: Body Mass Index; Calcium; Calcium Oxalate; Diagnosis, Differential; Female; Humans; Kidney Calculi; | 2014 |
Pathophysiological and physicochemical basis of ammonium urate stone formation in dolphins.
Topics: Animals; Bottle-Nosed Dolphin; Case-Control Studies; Chemical Phenomena; Female; Male; Nephrolithias | 2014 |
Age-related changes in 24-hour urine composition must be considered in the medical management of nephrolithiasis.
Topics: Adult; Age Factors; Aged; Ammonium Compounds; Analysis of Variance; Body Mass Index; Calcium; Calciu | 2014 |
Protein expression of urate transporters in renal tissue of patients with uric acid nephrolithiasis.
Topics: Adult; Gene Expression Regulation; Glucose Transport Proteins, Facilitative; Humans; Kidney; Male; M | 2014 |
Differences in 24-h urine composition between nephrolithiasis patients with and without diabetes mellitus.
Topics: Adult; Aged; Diabetes Complications; Female; Humans; Kidney Calculi; Male; Middle Aged; Nephrolithia | 2015 |
Re: body fat content and distribution and urinary risk factors for nephrolithiasis.
Topics: Adiposity; Calcium Oxalate; Humans; Male; Nephrolithiasis; Uric Acid | 2014 |
Theobromine inhibits uric acid crystallization. A potential application in the treatment of uric acid nephrolithiasis.
Topics: Caffeine; Crystallization; Humans; Microscopy, Electron, Scanning; Nephrolithiasis; Oxalates; Theobr | 2014 |
The Effect of Stone Composition on the Efficacy of Retrograde Intrarenal Surgery: Kidney Stones 1 - 3 cm in Diameter.
Topics: Adult; Calcium Oxalate; Calcium Phosphates; Female; Humans; Kidney; Kidney Calculi; Magnesium Compou | 2015 |
Preventive treatment of calcium oxalate crystal deposition with immortal flowers.
Topics: Animals; Citrates; Flowers; Helichrysum; Kidney; Male; Nephrolithiasis; Oxalates; Phytotherapy; Plan | 2015 |
[Uric acid nephrolithiasis].
Topics: Humans; Kidney Calculi; Nephrolithiasis; Uric Acid | 2015 |
Nephrolithiasis as a Risk Factor for CKD: The Atherosclerosis Risk in Communities Study.
Topics: Atherosclerosis; Female; Humans; Male; Middle Aged; Nephrolithiasis; Prospective Studies; Renal Insu | 2015 |
Bone remodeling markers as lithogenic risk factors in patients with osteopenia-osteoporosis.
Topics: Absorptiometry, Photon; Adult; Alkaline Phosphatase; Biomarkers; Bone Density; Bone Remodeling; Calc | 2016 |
Update on Nephrolithiasis: Core Curriculum 2016.
Topics: Acidosis, Renal Tubular; Calcium Phosphates; Curriculum; Cystinuria; Diet; Humans; Hyperoxaluria; Ne | 2016 |
Metabolic evaluation in patients with infected nephrolithiasis: Is it necessary?
Topics: Adolescent; Adult; Aged; Apatites; Calcium Oxalate; Citric Acid; Female; Follow-Up Studies; Humans; | 2016 |
[Litholytic therapy for urate nephrolithiasis].
Topics: Adult; Aged; Citric Acid; Female; Humans; Lithotripsy; Male; Middle Aged; Nephrolithiasis; Uric Acid | 2016 |
[Modern diagnostic and management aspects of citrate therapy for uric acid nephrolithiasis].
Topics: Citric Acid; Female; Humans; Male; Nephrolithiasis; Uric Acid | 2016 |
Kidney injury molecule-1 expression identifies proximal tubular injury in urate nephropathy.
Topics: Biopsy; Child; Creatinine; Female; Hepatitis A Virus Cellular Receptor 1; Humans; Kidney Tubules, Pr | 2008 |
Patients with nephrolithiasis and blood hypertension have higher calciuria than those with isolated nephrolithiasis or hypertension?
Topics: Adolescent; Adult; Algorithms; Calcium; Case-Control Studies; Humans; Hypertension; Insulin Resistan | 2009 |
Homozygous SLC2A9 mutations cause severe renal hypouricemia.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Animals; Child; Child, Preschool; Chromosome Mapping; | 2010 |
Relationship between body mass index and quantitative 24-hour urine chemistries in patients with nephrolithiasis.
Topics: Academic Medical Centers; Adult; Age Factors; Aged; Body Mass Index; Calcium Oxalate; Citric Acid; C | 2010 |
Hypocitraturia in common bottlenose dolphins (Tursiops truncatus): assessing a potential risk factor for urate nephrolithiasis.
Topics: Animals; Bottle-Nosed Dolphin; Citric Acid; Creatinine; Humans; Hydrogen-Ion Concentration; Nephroli | 2010 |
Lithogenic activity and clinical relevance of lipids extracted from urines and stones of nephrolithiasis patients.
Topics: Acidosis, Renal Tubular; Adult; Calcium Oxalate; Chromatography, Thin Layer; Deoxyguanosine; Female; | 2011 |
Application of a new method for GWAS in a related case/control sample with known pedigree structure: identification of new loci for nephrolithiasis.
Topics: Carrier Proteins; Case-Control Studies; Cohort Studies; Data Interpretation, Statistical; Genetic Lo | 2011 |
[Metabolic syndrome and nephrolithiasis].
Topics: Animals; Calcium; Humans; Hydrogen-Ion Concentration; Insulin Resistance; Metabolic Syndrome; Nephro | 2011 |
Fasting versus 24-h urine pH in the evaluation of nephrolithiasis.
Topics: Acidosis, Renal Tubular; Adult; Case-Control Studies; Fasting; Humans; Hydrogen-Ion Concentration; H | 2011 |
[Uric acid nephrolithiasis].
Topics: Humans; Nephrolithiasis; Uric Acid | 2011 |
Analysis of risk factors for uric acid nephrolithiasis in type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; Body Mass Index; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Cross-S | 2011 |
Urinary pH and renal lithiasis.
Topics: Calcium Oxalate; Calcium Phosphates; Crystallization; Humans; Hydrogen-Ion Concentration; Nephrolith | 2012 |
Effect of renal function on urinary mineral excretion and stone composition.
Topics: Adult; Calcium Phosphates; Female; Glomerular Filtration Rate; Humans; Hydrogen-Ion Concentration; K | 2011 |
Nephrolithiasis in medullary sponge kidney: evaluation of clinical and metabolic features.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Citric Acid; Diuresis; Female; Humans; Hypercalciuria; H | 2012 |
Microfluidic chip-capillary electrophoresis with dynamic multi-segment standard addition for rapidly identifying nephrolithiasis markers in urine.
Topics: Biomarkers; Citric Acid; Electrophoresis, Microchip; Equipment Design; Humans; Limit of Detection; N | 2011 |
Abnormalities of 24-hour urine composition in first-time and recurrent stone-formers.
Topics: Adult; Aged; Citric Acid; Female; Humans; Hypercalciuria; Hyperoxaluria; Linear Models; Male; Middle | 2012 |
[Diagnosis of nephrolithiasis with the aid of uric acid diathesis index].
Topics: Calculi; Disease Susceptibility; Humans; Kidney; Kidney Calculi; Nephrolithiasis; Uric Acid | 1959 |
[SOME METABOLIC ASPECTS OF RENAL LITHIASIS].
Topics: Calcium; Calcium, Dietary; Carbohydrate Metabolism; Glycine; Humans; Lithiasis; Mexico; Minerals; Ne | 1963 |
[PSYCHOSOMATIC STUDY OF RENAL LITHIASIS].
Topics: Humans; Kidney Calculi; Lithiasis; Nephrolithiasis; Oxalates; Phosphates; Psychophysiologic Disorder | 1963 |
[STUDY OF URINARY CITRATES IN RENAL LITHIASIS. PRELIMINARY RESULTS].
Topics: Citrates; Humans; Kidney Calculi; Lithiasis; Nephritis; Nephrolithiasis; Oxalates; Phosphates; Uric | 1964 |
[NEPHROLITHIASIS].
Topics: Blood; Body Fluids; Humans; Hypercalcemia; Hyperparathyroidism; Kidney Calculi; Nephrolithiasis; Oxa | 1965 |
Nephrolithiasis caused by abnormalities of calcium and uric acid metabolism.
Topics: Calcium; Humans; Kidney; Nephrolithiasis; Uric Acid | 1951 |
Some aspects of the management of bilateral calculus disease of the kidney.
Topics: Calcium Oxalate; Cystine; Humans; Kidney; Kidney Calculi; Lithiasis; Magnesium; Nephrolithiasis; Pho | 1950 |
Factors increasing the risk for stone formation in adult patients with cystic fibrosis.
Topics: Adult; Calcium Oxalate; Creatinine; Cystic Fibrosis; Female; Heterozygote; Humans; Hydrogen-Ion Conc | 2006 |
[Acute urate nephropathy in perimenopausal women].
Topics: Acute Disease; Adult; Female; Humans; Hyperuricemia; Kidney Tubules, Distal; Middle Aged; Nephrolith | 2006 |
Ceftriaxone associated nephrolithiasis: a prospective study in 284 children.
Topics: Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Creatinine; Cystine; Female; Humans; In | 2007 |
Urate nephrolithiasis in a northern elephant seal (Mirounga angustirostris) and a California sea lion (Zalophus californianus).
Topics: Animals; California; Fatal Outcome; Female; Kidney; Kidney Calculi; Male; Nephrolithiasis; Quaternar | 2007 |
Rare variant of Lesch-Nyhan syndrome without self-mutilation or nephrolithiasis.
Topics: Cerebral Palsy; Child; Diagnosis, Differential; Humans; Kidney; Lesch-Nyhan Syndrome; Male; Nephroca | 2007 |
Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers.
Topics: Adult; Age of Onset; Calcium Oxalate; Female; Humans; Kidney Diseases; Male; Metabolic Clearance Rat | 2007 |
Determinants of urinary calcium and uric acid excretion in children after renal transplantation.
Topics: Adolescent; Adult; Biomarkers; Calcium; Child; Child, Preschool; Female; Hematuria; Humans; Immunosu | 2007 |
Circadian variation in urine pH and uric acid nephrolithiasis risk.
Topics: Circadian Rhythm; Humans; Hydrogen-Ion Concentration; Nephrolithiasis; Risk Factors; Uric Acid; Urin | 2008 |
Diabetes and nephrolithiasis.
Topics: Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Nephrolithiasis; Prevalence; Uric Acid | 2007 |